Biotia uses genomic sequencing to identify pathogens in difficult infections, providing diagnostic tests and software for clinicians and laboratories.
Startup Funding News
New startup rounds, lead investors and the businesses behind the funding.
3 rounds · $26.5M disclosed · $13.3M median
| Company | Amount | Stage / sector | Lead investor | Announced |
|---|---|---|---|---|
| Biotia Biotia uses genomic sequencing to identify pathogens in difficult infections, providing diagnostic tests and software for clinicians and laboratories. | $9M | Undisclosed Diagnostics | — | |
| Spore.Bio Spore.Bio develops optical and AI systems that detect, quantify and identify microorganisms without conventional culture-based testing. | Undisclosed | Undisclosed Biotech | — | |
| ShanX Medtech ShanX Medtech develops diagnostic tests that measure microbial metabolism to identify which antibiotics can treat an infection. | €15M | Seed Medtech | Borski Fund, NextGen Ventures, CbusineZ, Brabantse Ontwikkelings Maatschappij, Invest-NL |
Spore.Bio develops optical and AI systems that detect, quantify and identify microorganisms without conventional culture-based testing.
ShanX Medtech develops diagnostic tests that measure microbial metabolism to identify which antibiotics can treat an infection.
Reports & briefings
September 2026 Startup Funding Report
98 sourced rounds, with company profiles and participating investors.
Sep 21 – 27, 2026 Startup Funding Weekly
31 sourced rounds, with company profiles and participating investors.
Sep 14 – 20, 2026 Startup Funding Weekly
8 sourced rounds, with company profiles and participating investors.
Active investors
| Investor | Rounds | Led | Recent investments |
|---|---|---|---|
| 01Y Combinator | 30 | 2 | Hop AeroSpott |
| 02Andreessen Horowitz | 26 | 11 | ArmadinEliseAI |
| 03Accel | 26 | 10 | ArmadinArivihan |
| 04Lightspeed Venture Partners | 26 | 6 | Temporal TechnologiesNeko Health |